Methylation testing

Methylation testing

DNA testing that detects if a gene is active or imprinted.
Mentioned in: Prader-Willi Syndrome
Mentioned in ?
References in periodicals archive ?
Although real-time PCR-based methylation testing for FXS is available (12) and is specific for FXS males carrying the FM with a methylated FMR1 CpG island located 5' of the expansion, there is currently no real-time PCR-based test that can be used to predict specific cognitive and behavioral impairments in female carriers with expanded FMR1 alleles.
She finds that she enjoys speaking with physicians and nurses about a vast array of tests, ranging from DNA methylation testing for Prader-Willi/Angelman Syndrome to immunodiffusion testing for Aspergilllus antibodies.
7) Methylation testing is more technically challenging than BRAF mutation testing is, so many pathologists have chosen BRAF testing as the more cost-effective clinical assay to distinguish sporadic from familial MSI-H CRC.
If BRAF mutation is present, the patient is unlikely to have Lynch syndrome, whereas those CRCs without BRAF mutation should be further evaluated using other tests, such as methylation testing for CpG (cytosine and guanine separated by a phosphate) island methylator phenotype, and immunohistochemistry for the MMR proteins, followed by sequencing of the relevant MMR genes whose product is not expressed in tumor cells.
Blinded methylation testing was performed on paraffin embedded prostate biopsy tissue.
Ongoing clinical trials have incorporated this now validated prognostic marker to determine if subsets of patients require alternative therapies, on the basis of prognostic information determined by the MGMT methylation testing.
LabCorp's Esoterix Clinical Trials Services Division was also selected by OncoMethylome as one of its preferred sub-contractors for MGMT methylation testing services for clinical trials.
LabCorp's Esoterix Clinical Trials Services Division was also selected by OncoMethylome as one of its preferred sub-contractors of MGMT methylation testing services for clinical trials.
announced today that the laboratory has been approved by the clinical trial supporter and OncoMethylome Science's collaborator, Schering-Plough Corporation, to provide MGMT methylation testing for OncoMethylome Sciences.